European Stocks Trading Below Estimated Value In August 2026
As European markets navigate the complexities of global bond sell-offs and inflationary pressures, investors are keenly observing opportunities within the region's equities. In this environment, identifying stocks that are trading below their estimated value can offer potential for growth, especially as economic indicators such as Germany's manufacturing momentum and improved eurozone activity provide a cautiously optimistic outlook.
Top 10 Undervalued Stocks Based On Cash Flows In Europe
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Vitrolife (OM:VITR) | SEK91.05 | SEK181.23 | 49.8% |
| Murapol (WSE:MUR) | PLN38.85 | PLN77.50 | 49.9% |
| Micro Systemation (OM:MSAB B) | SEK89.20 | SEK177.07 | 49.6% |
| Mare Group (BIT:MARE) | €4.94 | €9.87 | 50% |
| KB Components (OM:KBC) | SEK44.00 | SEK87.40 | 49.7% |
| Gabriel Holding (CPSE:GABR) | DKK262.00 | DKK522.09 | 49.8% |
| Endomines Finland Oyj (HLSE:PAMPALO) | €9.48 | €18.89 | 49.8% |
| Dynavox Group (OM:DYVOX) | SEK75.10 | SEK148.95 | 49.6% |
| Dellia Group (OB:DELIA) | NOK19.22 | NOK38.33 | 49.9% |
| Alimak Group (OM:ALIG) | SEK125.20 | SEK250.25 | 50% |
We're going to check out a few of the best picks from our screener tool.
Verisure (OM:VSURE)
Overview: Verisure plc offers security services to families and small businesses across Europe and Latin America, with a market cap of €9.70 billion.
Operations: The company's revenue is primarily derived from Portfolio Services (€3.48 billion), followed by Customer Acquisition (€351 million) and Adjacencies (€113.10 million).
Estimated Discount To Fair Value: 47.5%
Verisure is trading at €9.38, significantly below its estimated future cash flow value of €17.86, indicating it may be undervalued based on cash flows. Recent earnings results show a turnaround with net income of €3.8 million for Q2 2026, compared to a loss last year. However, the dividend yield of 2.13% is not well covered by earnings, and return on equity is forecasted to remain low at 10.2% in three years despite expected profitability improvements.
- The growth report we've compiled suggests that Verisure's future prospects could be on the up.
- Delve into the full analysis health report here for a deeper understanding of Verisure.
Galderma Group (SWX:GALD)
Overview: Galderma Group AG is a global dermatology company with a market capitalization of CHF40.00 billion.
Operations: The company generates revenue from its Dermatology segment, amounting to $5.92 billion.
Estimated Discount To Fair Value: 42.4%
Galderma Group is trading at CHF171.55, significantly below its estimated future cash flow value of CHF297.67, suggesting potential undervaluation based on cash flows. The company reported strong earnings growth with net income rising to US$444 million for H1 2026 from US$194 million a year ago. However, despite robust profit forecasts and recent product innovations like Restylane Shaype in the EU market, return on equity is expected to remain modest at 16.5%.
- Insights from our recent growth report point to a promising forecast for Galderma Group's business outlook.
- Take a closer look at Galderma Group's balance sheet health here in our report.
IONOS Group (XTRA:IOS)
Overview: IONOS Group SE, along with its subsidiaries, offers web presence and productivity services as well as cloud solutions to businesses in several countries including Germany, the United States, and the United Kingdom, with a market capitalization of approximately €4.57 billion.
Operations: The company's revenue is primarily derived from its Web Presence & Productivity and Cloud Solutions segment, which generated €1.36 billion.
Estimated Discount To Fair Value: 39.8%
IONOS Group, trading at €33.94, is significantly below its future cash flow value of €56.4, indicating undervaluation based on cash flows. The company forecasts earnings growth of 15.32% annually, outpacing the German market slightly. Despite a high debt level and modest net income decline in H1 2026 to €107.79 million from the previous year, recent guidance revisions show improved revenue expectations for 2026 at approximately 8-9%.
- Our growth report here indicates IONOS Group may be poised for an improving outlook.
- Click here to discover the nuances of IONOS Group with our detailed financial health report.
Summing It All Up
- Unlock our comprehensive list of 217 Undervalued European Stocks Based On Cash Flows by clicking here.
- Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
- Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.
Ready To Venture Into Other Investment Styles?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com